Sun Pharma Completes Acquisition of Concert Pharmaceuticals PR Newswire MUMBAI, India and PRINCETON, N.J., March 6, 2023 Acquisition Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, to Sun Pharma's Global Dermatology Portfolio MUMBAI, India and PRINCETON, N.J. , March 6, 2023 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together with its subsidiaries and/or...